Concepedia

Xianhua Cao

XC

19

Publications

1.8K

Citations

19

H-Index

1995

Active since

Affiliations

The Ohio State University(Current)

Center for Drug Evaluation and Research

Lung Institute

Boehringer Ingelheim (United States)

Xianhua Cao is an author at The Ohio State University specializing in medicine, cancer research, and pharmacology.

Top concepts

Publications per year

1995–2018

19

Publications

19

A novel Hsp90 inhibitor to disrupt Hsp90/Cdc37 complex against pancreatic cancer cells

Tao Zhang, Adel Hamza, Xianhua Cao et al. · Molecular Cancer Therapeutics · 2008 · 367 citations · Full text

Glucose uptake inhibitor sensitizes cancer cells to daunorubicin and overcomes drug resistance in hypoxia

Xianhua Cao, Lanyan Fang, Seth Gibbs et al. · Cancer Chemotherapy and Pharmacology · 2006 · 219 citations

, , +11

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab

Maitreyee Hazarika, Meredith K. Chuk, Marc R. Theoret et al. · Clinical Cancer Research · 2017 · 181 citations

Lipopolysaccharide-Induced Macrophage Inflammatory Response Is Regulated by SHIP

Huiqing Fang, Ruma A. Pengal, Xianhua Cao et al. · The Journal of Immunology · 2004 · 170 citations · Full text

Synthesis and Enzyme-Specific Activation of Carbohydrate−Geldanamycin Conjugates with Potent Anticancer Activity

Hao Cheng, Xianhua Cao, Ming Xian et al. · Journal of Medicinal Chemistry · 2004 · 112 citations

Rows per page

1–5 of 19